PHYSICAL THERAPY IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH): RESULTS FROM A GERMAN CLAIMS DATA ANALYSIS

被引：0
|
作者：
Barthuber, L. [1 ]
Nill, I [1 ]
Jacob, C. [2 ]
Schmid, T. [1 ]
机构：
[1] MSD Sharp & Dohme GmbH, Munich, By, Germany
[2] Xcenda GmbH, Hannover, Germany
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD44
引用
收藏
页码：S334 / S334
页数：1
相关论文
共 50 条
  • [21] INITIAL DATA FROM THE US PULMONARY HYPERTENSION REGISTRY: GENETICS AND DEMOGRAPHICS IN NEWLY DIAGNOSED PULMONARY ARTERIAL HYPERTENSION (PAH)
    Benza, Raymond
    Frost, Adaani
    Elliott, Greg
    Austin, Eric
    Badesch, David
    Farber, Harrison
    Chung, Wendy
    Poms, Abby
    Feldkircher, Kathy
    Yu, Chang
    Badlam, Jessica
    Pauciulo, Michael
    Nichols, William
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1926 - 1926
  • [22] Expert Council resolution on pulmonary arterial hypertension (PAH) "Changing the paradigm of treating patients with pulmonary arterial hypertension"
    Chazova, I. E.
    Martynyuk, T. V.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (03) : 114 - 116
  • [23] Early Experiences with Macitentan Therapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
    Minnock, C.
    Murray, M.
    Gaine, S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 : S517 - S517
  • [24] Initial combination therapy for patients with pulmonary arterial hypertension (PAH): a budget impact analysis from the perspective of the Italian national healthcare system
    Barbieri, Marco
    Ghio, Stefano
    D'Alto, Michele
    Albera, Carlo
    Carignola, Renato
    Mule, Massimiliano
    Vitulo, Patrizio
    Vighini, Miriam
    Silvestri, Rosaria
    Zamboni, William
    Vizza, Carmine Dario
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (01): : 1 - 7
  • [25] Results of a Planned Analysis of the Effects of Genetic Background on Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
    Montani, D.
    Mclaughlin, V. V.
    Gibbs, J. S. R.
    Gomberg-Maitland, M.
    Hoeper, M. M.
    Preston, I. R.
    Souza, R.
    Waxman, A. B.
    Subias, P. Escribano
    Feldman, J. P.
    Meyer, G. Bohns
    Olsson, K. M.
    Manimaran, S.
    Zhao, Y.
    Lau, A.
    Pena, J.
    Badesch, D. B.
    Humbert, M. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [26] Retrospective Analysis Of Prescription Claims Following Discharge In Pulmonary Arterial Hypertension Patients
    George, S.
    Rayburn, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [27] Long-term sitaxsentan therapy in Pulmonary Arterial Hypertension (PAH)
    Horn, E
    Langleben, D
    Frost, A
    Hill, N
    McLaughlin, V
    Oudiz, R
    Dixon, RAF
    Barst, RJ
    EUROPEAN HEART JOURNAL, 2004, 25 : 466 - 466
  • [28] Real-world Use of Upfront Combination Therapy in Pulmonary Arterial Hypertension (PAH) Patients
    Paoli, C.
    Tang, W.
    Panjabi, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [29] Longitudinal Hemodynamic Changes in Pediatric Patients with Severe Pulmonary Arterial Hypertension (PAH) on Prostanoid Therapy
    Siehr, S. L.
    Ivy, D.
    Miller-Reed, K.
    Ogawa, M.
    Rosenthal, D.
    Feinstein, J. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S72 - S72
  • [30] Effect of riociguat on pulmonary arterial compliance in patients with pulmonary arterial hypertension (PAH) in the RESPITE study
    Hoeper, Marius M.
    Corris, Paul A.
    Ghofrani, Hossein-Ardeschir
    Klinger, James R.
    Langleben, David
    Naeije, Robert
    Simonneau, Gerald
    Jansa, Pavel
    Rosenkranz, Stephan
    Grunig, Ekkehard
    Scelsi, Laura
    Meier, Christian
    Busse, Dennis
    Benza, Raymond L.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
12345